Organogenesis Holdings Inc (NASDAQ: ORGO) stock jumped 4.74% on Friday to $2.65 against a previous-day closing price of $2.53. With 0.79 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.88 million shares. The 52-week range on ORGO shows that it touched its highest point at $4.50 and its lowest point at $1.79 during that stretch. It currently has a 1-year price target of $3.75.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ORGO was up-trending over the past week, with a rise of 21.00%, but this was up by 13.73% over a month. Three-month performance surged to 3.52% while six-month performance fell -17.19%. The stock lost -1.85% in the past year, while it has lost -1.49% so far this year. A look at the trailing 12-month EPS for ORGO yields 0.10 with Next year EPS estimates of 0.08. For the next quarter, that number is 0.01. This implies an EPS growth rate of -65.12% for this year and 14.29% for next year.
Float and Shares Shorts:
At present, 130.92 million ORGO shares are outstanding with a float of 78.50 million shares on hand for trading. On Oct 30, 2023, short shares totaled 4.77 million, which was 3.63% higher than short shares on Sep 28, 2023. In addition to Mr. Gary S. Gillheeney Sr. as the firm’s President, CEO, Chair of the Board, Mr. David C. Francisco serves as its Chief Financial Officer.
Through their ownership of 41.69% of ORGO’s outstanding shares, institutional investors have minority control over the company.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ORGO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ORGO analysts setting a high price target of $4.00 and a low target of $3.50, the average target price over the next 12 months is $3.75. Based on these targets, ORGO could surge 50.94% to reach the target high and rise by 32.08% to reach the target low. Reaching the average price target will result in a growth of 41.51% from current levels.
Summary of Insider Activity:
Insiders traded ORGO stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 13 while that of sell transactions has risen to 19 over the past year. The total number of shares bought during that period was 2,533,051 while 111,801 shares were sold.